Saniona AB Sustainability Reports
Saniona AB is a clinical-stage biopharmaceutical company focused on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders. The company leverages its proprietary ion channel drug discovery platform to develop a pipeline of therapeutics targeting rare diseases, epilepsy, and other central nervous system conditions.
Sector: Manufacturing
Country: Denmark
Exchange: Nasdaq Stockholm
LEI: 549300XO4L9XNOCFCZ84
FIGI: BBG0063H3MF7
11 reports from 2014 to 2025